Antiplatelet pyrimido-pyrimidines and metastasis
- 31 December 1985
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 12 (4) , 221-234
- https://doi.org/10.1016/0305-7372(85)90006-4
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Tumor‐cell‐platelet aggregation does not correlate with metastatic potential of rat 13762NF mammary adenocarcinoma tumor cell clonesInternational Journal of Cancer, 1984
- Enhancement of the Immune Response to Sheep Erythrocytes in Mice by Phosphodiesterase-Inhibiting Dipyridamole DerivativesJournal of Immunopharmacology, 1984
- Forskolin: A potential antimetastatic agentInternational Journal of Cancer, 1983
- New developments in calcium ion channel antagonistsJournal of Medicinal Chemistry, 1983
- The effect of 2,6-bis(diethanolamino)-4-piperidinopyrimido [5,4-d]-pyrimidine (RA233) on growth, metastases and lung colony formation of B16 melanomaCancer Letters, 1982
- How pure are inbred strains of mice?Immunology Today, 1982
- Prostacyclin: A Potent Antimetastatic AgentScience, 1981
- Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cellsNature, 1979
- Control of DNA synthesis and mitosis in 3T3 cells by cyclic AMPBiochemical and Biophysical Research Communications, 1972
- THE INHIBITION OF THE CANCER CELL STICKINESS BY PYRIMIDO‐PYRIMIDINE DERIVATES INDUCED BY INHIBITION OF PLATELET AGGREGATIONActa Medica Scandinavica, 1972